Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1332203

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1332203

Monocyte Activation Tests

PUBLISHED:
PAGES: 244 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Monocyte Activation Tests Market to Reach $29.8 Million by 2030

In the changed post COVID-19 business landscape, the global market for Monocyte Activation Tests estimated at US$10.8 Million in the year 2022, is projected to reach a revised size of US$29.8 Million by 2030, growing at aCAGR of 13.5% over the period 2022-2030. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$16.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Million, While China is Forecast to Grow at 12.9% CAGR

The Monocyte Activation Tests market in the U.S. is estimated at US$3.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.1 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson & Company
  • Charles River Laboratories International, Inc.
  • Lonza Group AG
  • Merck KgaA
  • Microcoat Biotechnologie GmbH
  • Sanquin
  • Solvias AG
  • Thermo Fisher Scientific, Inc.
Show more
Product Code: MCP16601

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Monocyte Activation Tests - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Monocyte Activation Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Monocyte Activation Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Blood Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Peripheral Blood Mononuclear Cell (PBMC) Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cell Line Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Cell Line Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Use Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Other End-Use Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Monocyte Activation Tests Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • JAPAN
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • CHINA
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • EUROPE
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Monocyte Activation Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • FRANCE
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • GERMANY
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • UNITED KINGDOM
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Monocyte Activation Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Product - Monocyte Activation Test Kits and Reagents - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Monocyte Activation Tests by Product - Percentage Breakdown of Value Sales for Monocyte Activation Test Kits and Reagents for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by Source - Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Monocyte Activation Tests by Source - Percentage Breakdown of Value Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell Line Based for the Years 2023 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Monocyte Activation Tests by End-Use Industry - Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Monocyte Activation Tests by End-Use Industry - Percentage Breakdown of Value Sales for Pharmaceuticals, Biotechnology, Medical Devices and Other End-Use Industries for the Years 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!